triclosan [Ligand Id: 14492] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL849 (CH 3565, Stri-dex cleansing bar, Triclosan, Tegusept, CH-3565, NSC-759151, DNDI1246774, Triclosan component of colgate total, Innoxa, Skinsan, Aquasept, Gamophen, Manusept, Cloxifenol)
  • CBR1/Carbonyl reductase [NADPH] 1 in Human [ChEMBL: CHEMBL5586] [GtoPdb: 1383] [UniProtKB: P16152]
There should be some charts here, you may need to enable JavaScript!
  • heat shock protein family A (Hsp70) member 5/Endoplasmic reticulum chaperone BiP in Human [ChEMBL: CHEMBL1781865] [GtoPdb: 3193] [UniProtKB: P11021]
There should be some charts here, you may need to enable JavaScript!
  • Enoyl-acyl-carrier protein reductase in Plasmodium falciparum [ChEMBL: CHEMBL4150] [UniProtKB: Q965D5]
There should be some charts here, you may need to enable JavaScript!
  • Enoyl-(Acyl-carrier-protein) reductase in Streptococcus pneumoniae [ChEMBL: CHEMBL1075024] [UniProtKB: Q9FBC5]
There should be some charts here, you may need to enable JavaScript!
  • Enoyl-[acyl-carrier-protein] reductase [NADH] in Mycobacterium tuberculosis [ChEMBL: CHEMBL1849] [UniProtKB: P9WGR1]
  • Enoyl-[acyl-carrier-protein] reductase [NADH] in Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) [ChEMBL: CHEMBL2150835] [UniProtKB: Q5NGQ3]
There should be some charts here, you may need to enable JavaScript!
  • Enoyl-[acyl-carrier-protein] reductase [NADH] FabI in Escherichia coli [ChEMBL: CHEMBL1857] [UniProtKB: P0AEK4]
  • Enoyl-[acyl-carrier-protein] reductase [NADH] FabI in Bacillus subtilis (strain 168) [ChEMBL: CHEMBL1075044] [UniProtKB: P54616]
There should be some charts here, you may need to enable JavaScript!
  • Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI in S.aureus [ChEMBL: CHEMBL3994] [UniProtKB: Q6GI75]
There should be some charts here, you may need to enable JavaScript!
  • Enoyl-acyl carrier reductase in Toxoplasma gondii [ChEMBL: CHEMBL1250368] [UniProtKB: Q6UCJ9]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
CBR1/Carbonyl reductase [NADPH] 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5586] [GtoPdb: 1383] [UniProtKB: P16152]
ChEMBL Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as NADPH oxidation using isatin as substrate B 7.22 pKi 60 nM Ki Bioorg Med Chem (2009) 17: 530-536 [PMID:19097799]
ChEMBL Binding affinity to human recombinant carbonyl reductase 1 expressed in Escherichia coli assessed as NADPH oxidation using isatin as substrate B 6.4 pIC50 400 nM IC50 Bioorg Med Chem (2009) 17: 530-536 [PMID:19097799]
heat shock protein family A (Hsp70) member 5/Endoplasmic reticulum chaperone BiP in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1781865] [GtoPdb: 3193] [UniProtKB: P11021]
ChEMBL Inhibition of GRP78 (26 to 636 residues) (unknown origin) expressed in Escherichia coli BL21 DE3 cells pre-incubated for 10 mins before FITC-NRLLLTG fluorescent peptide addition in presence of 20 uM ADP followed by further incubation for 2 hrs by fluorescence polarization assay B 4 pIC50 100000 nM IC50 Bioorg Med Chem Lett (2019) 29: 1689-1693 [PMID:31129054]
Enoyl-acyl-carrier protein reductase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4150] [UniProtKB: Q965D5]
ChEMBL Inhibition of Plasmodium falciparum recombinant enoyl ACP reductase expressed in BL21 (DE3) cells with respect to crotonyl CoA B 6.18 pKi 660 nM Ki J Med Chem (2007) 50: 2665-2675 [PMID:17477517]
ChEMBL Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of butein B 7.15 pKi 71.02 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of EGC B 7.28 pKi 52.71 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum enoyl-acyl carrier protein reductase expressed in Escherichia coli BL21(DE3) by spectrophotometry B 7.3 pKi 50 nM Ki Eur J Med Chem (2009) 44: 3009-3019 [PMID:19217192]
ChEMBL Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of quercetin B 7.52 pKi 30.54 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of ECG B 7.55 pKi 28.31 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of butein B 7.86 pKi 13.72 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of quercetin B 8 pKi 10 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of EGC B 8.08 pKi 8.25 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of ECG B 8.1 pKi 8 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR by fluorescence quenching in presence of EGCG B 8.14 pKi 7.29 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of EGCG B 9 pKi 1 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of butein by dilution assay B 9.1 pKi 0.8 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of quercetin by dilution assay B 9.55 pKi 0.28 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of EGC by dilution assay B 9.96 pKi 0.11 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum ENR in presence of ECG by dilution assay B 10.28 pKi 0.05 nM Ki J Med Chem (2007) 50: 765-775 [PMID:17263522]
ChEMBL Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry B 6.7 pIC50 200 nM IC50 J Nat Prod (2011) 74: 1370-1378 [PMID:21619045]
ChEMBL Inhibition of Plasmodium falciparum enoyl-acyl carrier protein reductase B 7.14 pIC50 73 nM IC50 Eur J Med Chem (2009) 44: 3009-3019 [PMID:19217192]
ChEMBL Inhibition of PfENR enzymatic activity B 7.14 pIC50 73 nM IC50 Bioorg Med Chem Lett (2005) 15: 5247-5252 [PMID:16198563]
ChEMBL Inhibition of Plasmodium falciparum ENR B 7.14 pIC50 73 nM IC50 J Biol Chem (2007) 282: 25436-25444 [PMID:17567585]
ChEMBL Inhibition of Plasmodium falciparum ENR enzymatic activity B 7.14 pIC50 73 nM IC50 Bioorg Med Chem Lett (2006) 16: 2163-2169 [PMID:16466916]
ChEMBL Inhibition of Plasmodium falciparum enoyl-ACP reductase assessed as oxidation of NADH to NAD+ after 10 mins by spectrophotometric analysis B 7.15 pIC50 70 nM IC50 Bioorg Med Chem Lett (2012) 22: 610-612 [PMID:22082562]
ChEMBL Inhibition of Plasmodium falciparum recombinant FabI B 7.15 pIC50 70 nM IC50 Antimicrob Agents Chemother (2007) 51: 2552-2558 [PMID:17485508]
ChEMBL Inhibition of Plasmodium falciparum recombinant enoyl ACP reductase expressed in BL21 (DE3) cells B 7.18 pIC50 66 nM IC50 J Med Chem (2007) 50: 2665-2675 [PMID:17477517]
Enoyl-(Acyl-carrier-protein) reductase in Streptococcus pneumoniae (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075024] [UniProtKB: Q9FBC5]
ChEMBL Inhibition of Streptococcus pneumoniae FabK B 4.49 pIC50 >32000 nM IC50 J Med Chem (2007) 50: 4710-4720 [PMID:17713898]
ChEMBL Inhibition of Streptococcus pneumoniae enoyl-ACP reductase FabK B 4.49 pIC50 >32000 nM IC50 Bioorg Med Chem (2007) 15: 7325-7336 [PMID:17892940]
Enoyl-[acyl-carrier-protein] reductase [NADH] in Mycobacterium tuberculosis (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1849] [UniProtKB: P9WGR1]
ChEMBL Inhibition of Mycobacterium tuberculosis InhA B 6.66 pKi 220 nM Ki Eur J Med Chem (2018) 146: 318-343 [PMID:29407960]
ChEMBL Inhibition of Mycobacterium tuberculosis H37RV InhA B 6.7 pKi 200 nM Ki Bioorg Med Chem Lett (2008) 18: 3029-3033 [PMID:18457948]
ChEMBL Uncompetitive inhibition of Mycobacterium tuberculosis InhA using trans-2-dodecenoyl-CoA as substrate in presence of NADH B 6.7 pKi 200 nM Ki Eur J Med Chem (2018) 146: 318-343 [PMID:29407960]
ChEMBL Inhibition of Mycobacterial tuberculosis ATCC 25618 FabI assessed as measuring NADH consumption rate B 6.7 pKi 200 nM Ki Eur J Med Chem (2020) 208: 112757-112757 [PMID:32883635]
ChEMBL Binding affinity to Mycobacterium tuberculosis InhA B 6.7 pKi 200 nM Ki Eur J Med Chem (2018) 150: 525-545 [PMID:29549838]
ChEMBL Inhibition of Mycobacterium tuberculosis InhA using trans-2-decenoyl-N-acetylcysteamine as substrate preincubated for 1 hr followed by substrate addition measured every 30 secs for 5 mins B 5 pIC50 10000 nM IC50 Bioorg Med Chem Lett (2018) 28: 2084-2090 [PMID:29748048]
ChEMBL Inhibition of recombinant Mycobacterium tuberculosis InhA expressed in Escherichia coli Rosette(DE3) pLysS using trans-2-decenoyl-N-acetylcysteamine as substrate by spectrophotometric method B 5.21 pIC50 6140 nM IC50 Bioorg Med Chem (2019) 27: 1509-1516 [PMID:30846404]
ChEMBL inhibition of Mycobacterium tuberculosis InhA after 20 mins by fluorometric assay B 5.52 pIC50 3000 nM IC50 J Nat Prod (2002) 65: 1037-1038 [PMID:12141869]
ChEMBL Inhibition of Mycobacterium tuberculosis InhA B 6 pIC50 1000 nM IC50 Eur J Med Chem (2018) 146: 318-343 [PMID:29407960]
ChEMBL Inhibition of Mycobacterium tuberculosis InhA using DD-CoA as substrate B 6 pIC50 1000 nM IC50 RSC Med Chem (2021) 12: 120-128 [PMID:34046604]
ChEMBL Inhibition of Mycobacterium tuberculosis InhA using dodecyl coA as substrate by LC-MS/MS analysis B 6.2 pIC50 630 nM IC50 ACS Med Chem Lett (2014) 5: 1005-1009 [PMID:25221657]
ChEMBL Inhibition of wild type Mycobacterium tuberculosis inhA B 6.7 pIC50 200 nM IC50 J Med Chem (2013) 56: 8533-8542 [PMID:24107081]
Enoyl-[acyl-carrier-protein] reductase [NADH] in Francisella tularensis subsp. tularensis (strain SCHU S4 / Schu 4) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2150835] [UniProtKB: Q5NGQ3]
ChEMBL Inhibition of Francisella tularensis SCHU S4 FabI F93V mutant using CrCoA as substrate by UV-vis spectrophotometric analysis in presence of non pre-equilibrated NAD+ B 4.85 pIC50 14000 nM IC50 J Med Chem (2013) 56: 5275-5287 [PMID:23815100]
ChEMBL Inhibition of Francisella tularensis SCHU S4 FabI F203L mutant using CrCoA as substrate by UV-vis spectrophotometric analysis in presence of non pre-equilibrated NAD+ B 5.22 pIC50 6000 nM IC50 J Med Chem (2013) 56: 5275-5287 [PMID:23815100]
ChEMBL Inhibition of C-terminal His6-tagged wild type Francisella tularensis SCHU S4 FabI expressed in Escherichia coli BL21 (DE3) using CrCoA as substrate by UV-vis spectrophotometric analysis in presence of non pre-equilibrated NAD+ B 5.89 pIC50 1300 nM IC50 J Med Chem (2013) 56: 5275-5287 [PMID:23815100]
ChEMBL Inhibition of Francisella tularensis SCHU S4 FabI R96M mutant using CrCoA as substrate by UV-vis spectrophotometric analysis in presence of non pre-equilibrated NAD+ B 6.52 pIC50 300 nM IC50 J Med Chem (2013) 56: 5275-5287 [PMID:23815100]
ChEMBL Inhibition of Francisella tularensis SCHU S4 FabI R96G mutant using CrCoA as substrate by UV-vis spectrophotometric analysis in presence of non pre-equilibrated NAD+ B 7.3 pIC50 50 nM IC50 J Med Chem (2013) 56: 5275-5287 [PMID:23815100]
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI in Escherichia coli (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1857] [UniProtKB: P0AEK4]
ChEMBL Inhibition of Escherichia coli enoyl-ACP reductase FabI B 6.05 pIC50 900 nM IC50 Bioorg Med Chem (2007) 15: 7325-7336 [PMID:17892940]
ChEMBL Antibacterial activity against Escherichia coli FabI B 6.37 pIC50 430 nM IC50 Bioorg Med Chem Lett (2001) 11: 2241-2244 [PMID:11527706]
ChEMBL Evaluated for inhibition of enoyl acyl carrier protein reductase (FabI) in Escherichia coli. B 6.37 pIC50 430 nM IC50 Bioorg Med Chem Lett (2001) 11: 2061-2065 [PMID:11514139]
ChEMBL Inhibition of Escherichia coli FabI using crotonoyl-CoA as substrate preincubated for 90 mins B 6.77 pIC50 170 nM IC50 J Med Chem (2012) 55: 9914-9928 [PMID:23092194]
ChEMBL Inhibition of Escherichia coli FabI using 2-dodecenoyl-CoA as substrate at pH 8 B 8.3 pIC50 5 nM IC50 J Nat Prod (2013) 76: 1064-1070 [PMID:23806111]
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI in Bacillus subtilis (strain 168) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075044] [UniProtKB: P54616]
ChEMBL Inhibition of Bacillus anthracis Enoyl ACP reductase B 6.3 pIC50 500 nM IC50 Bioorg Med Chem Lett (2008) 18: 3565-3569 [PMID:18499454]
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI in S.aureus (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3994] [UniProtKB: Q6GI75]
ChEMBL Inhibition of Staphylococcus aureus FabI in the presence of NADH using crotonyl CoA as substrate by measuring NADH consumption rate B 8.3 pKi 5 nM Ki Eur J Med Chem (2020) 208: 112757-112757 [PMID:32883635]
ChEMBL Antibacterial activity against Staphylococcus aureus FabI B 5.96 pIC50 1100 nM IC50 Bioorg Med Chem Lett (2001) 11: 2241-2244 [PMID:11527706]
ChEMBL Evaluated for inhibition of enoyl acyl carrier protein reductase (FabI) in Staphylococcus aureus. B 5.96 pIC50 1100 nM IC50 Bioorg Med Chem Lett (2001) 11: 2061-2065 [PMID:11514139]
ChEMBL Inhibition of Staphylococcus aureus FabI assessed as reduction in inhibition of reduction of trans-2-octenoyl N-acetylcysteamine substrate by spectrophotometry B 6.36 pIC50 440 nM IC50 Bioorg Med Chem Lett (2015) 25: 4481-4486 [PMID:26343826]
ChEMBL Inhibitory activity against Enoyl-ACP reductase FabI in Staphylococcus aureus B 7.15 pIC50 70 nM IC50 J Med Chem (2003) 46: 1627-1635 [PMID:12699381]
ChEMBL Concentration required for the 50% inhibition of enoyl-ACP reductase from Staphylococcus aureus was determined. B 7.15 pIC50 70 nM IC50 J Med Chem (2002) 45: 3246-3256 [PMID:12109908]
ChEMBL Inhibition of Staphylococcus aureus recombinant FabI using trans-2-octenoyl N-acetylcysteamine thioester as substrate preincubated for 60 mins B 7.23 pIC50 59 nM IC50 J Med Chem (2012) 55: 9914-9928 [PMID:23092194]
Enoyl-acyl carrier reductase in Toxoplasma gondii (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1250368] [UniProtKB: Q6UCJ9]
ChEMBL Inhibition of Toxoplasma gondii enoyl reductase B 7.7 pIC50 <20 nM IC50 J Med Chem (2010) 53: 6287-6300 [PMID:20698542]
ChEMBL Inhibition of Toxoplasma gondii enoyl reductase assessed as conversion of trans-2-acyl-ACP to acyl-ACP B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2013) 23: 2035-2043 [PMID:23453069]
ChEMBL Inhibition of Toxoplasma gondii enoyl acyl-carrier protein reductase B 7.82 pIC50 15 nM IC50 Bioorg Med Chem Lett (2013) 23: 3551-3555 [PMID:23664871]
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364]
ChEMBL Antimalarial activity after 48 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake F 5.2 pIC50 6258 nM IC50 J Biol Chem (2007) 282: 2494-2504 [PMID:17110371]
ChEMBL Antimalarial activity after 96 hrs against Plasmodium falciparum Dd2 by [3H]hypoxanthine uptake F 5.38 pIC50 4186 nM IC50 J Biol Chem (2007) 282: 2494-2504 [PMID:17110371]
ChEMBL Antimalarial activity after 48 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake F 5.57 pIC50 2708 nM IC50 J Biol Chem (2007) 282: 2494-2504 [PMID:17110371]
ChEMBL Antimalarial activity against chloroquine-sensitive Plasmodium falciparum FCK2 F 5.64 pIC50 2290 nM IC50 Bioorg Med Chem (2008) 16: 5536-5546 [PMID:18434169]
ChEMBL Antimalarial activity after 96 hrs against Plasmodium falciparum GCO3 by [3H]hypoxanthine uptake F 5.82 pIC50 1526 nM IC50 J Biol Chem (2007) 282: 2494-2504 [PMID:17110371]
ChEMBL Antiplasmodial activity against chloroquine/pyrimethamine-resistant Plasmodium falciparum K1 assessed as growth inhibition after 24 hrs by [3H]-hypoxanthine incorporation assay F 5.82 pIC50 1510 nM IC50 J Med Chem (2013) 56: 7516-7526 [PMID:24063369]
ChEMBL Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 96 hrs F 5.92 pIC50 1200 nM IC50 Antimicrob Agents Chemother (2007) 51: 307-316 [PMID:17060533]
ChEMBL Inhibition of Plasmodium falciparum FCK2 growth as [3H]hypoxanthine uptake after 48 hrs F 5.96 pIC50 1100 nM IC50 Antimicrob Agents Chemother (2007) 51: 307-316 [PMID:17060533]
ChEMBL Antiplasmodial activity against asexual blood stage form of Plasmodium falciparum assessed as growth inhibition after 72 hrs by [3H]-hypoxanthine incorporation assay F 6 pIC50 1000 nM IC50 J Med Chem (2013) 56: 7516-7526 [PMID:24063369]
ChEMBL Antimalarial activity after 48 hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake F 6.11 pIC50 773.9 nM IC50 J Biol Chem (2007) 282: 2494-2504 [PMID:17110371]
ChEMBL Antiparasitic activity against Plasmodium falciparum in RBCs F 6.15 pIC50 700 nM IC50 Antimicrob Agents Chemother (2007) 51: 2552-2558 [PMID:17485508]
ChEMBL Antimalarial activity after 96hrs against Plasmodium falciparum 7G8 by [3H]hypoxanthine uptake F 6.37 pIC50 424.4 nM IC50 J Biol Chem (2007) 282: 2494-2504 [PMID:17110371]
ChEMBL Inhibition of drug-resistant Plasmodium falciparum Dd2 after 72 hrs F 5.41 pEC50 3900 nM EC50 Bioorg Med Chem Lett (2005) 15: 5247-5252 [PMID:16198563]
ChEMBL Antimalarial activity against Plasmodium falciparum Dd2 by reduced [3H]hypoxanthine uptake F 5.42 pEC50 3800 nM EC50 J Biol Chem (2007) 282: 25436-25444 [PMID:17567585]
ChEMBL Antimalarial activity against Plasmodium falciparum Dd2 assessed as inhibition of parasite growth F 5.42 pEC50 3800 nM EC50 Bioorg Med Chem Lett (2013) 23: 1022-1025 [PMID:23313245]
ChEMBL Antimalarial activity against Plasmodium falciparum Dd2 F 5.42 pEC50 3800 nM EC50 Bioorg Med Chem Lett (2006) 16: 2163-2169 [PMID:16466916]
ChEMBL Inhibition of drug-sensitive Plasmodium falciparum 3D7 after 72 hrs F 5.54 pEC50 2900 nM EC50 Bioorg Med Chem Lett (2005) 15: 5247-5252 [PMID:16198563]
ChEMBL Antimalarial activity against Plasmodium falciparum 3D7 F 5.54 pEC50 2900 nM EC50 Bioorg Med Chem Lett (2006) 16: 2163-2169 [PMID:16466916]
ChEMBL Antimalarial activity against Plasmodium falciparum 3D7 assessed as inhibition of parasite growth F 5.54 pEC50 2900 nM EC50 Bioorg Med Chem Lett (2013) 23: 1022-1025 [PMID:23313245]
ChEMBL Antimalarial activity against Plasmodium falciparum 3D7 by reduced [3H]hypoxanthine uptake F 5.55 pEC50 2800 nM EC50 J Biol Chem (2007) 282: 25436-25444 [PMID:17567585]
ChEMBL Antiplasmodial activity against Plasmodium falciparum 3D7 F 5.81 pEC50 1550 nM EC50 Eur J Med Chem (2021) 224: 113722-113722 [PMID:34364164]
transthyretin/Transthyretin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3194] [GtoPdb: 2851] [UniProtKB: P02766]
ChEMBL Binding affinity to wildtype TTR (unknown origin) assessed as dissociation constant by ITC analysis B 6.32 pKd 484 nM Kd J Med Chem (2025) 68: 1572-1586 [PMID:39761163]
ChEMBL Inhibition of acid-mediated TTR V30M mutant (unknown origin) aggregation preincubated for 30 mins followed by sodium acetate buffer at pH 5.2 addition and measured after 7 days by absorbance based turbidity assay B 4.74 pKi 18000 nM Ki J Med Chem (2025) 68: 1572-1586 [PMID:39761163]
ChEMBL Inhibition of transthyretin fibril formation at pH 4.4 F 4.27 pIC50 53500 nM IC50 J Med Chem (2007) 50: 5589-5599 [PMID:17948976]

ChEMBL data shown on this page come from version 37:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]